Targeted Medical Pharma competitorsClear all

Targeted Medical Pharma's top competitors include Athersys, Otonomy, Ironwood Pharmaceuticals and MyoKardia.
Targeted Medical Pharma
Targeted Medical Pharma
Targeted Medical Pharma is a specialty pharmaceutical company focused on development and commercialization of innovative nutrient pharmaceutical systems which provide treatment for various disease states.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Founding Date
Founding Date
1999
Founding Date
1995
Founding Date
2008
Founding Date
N/A
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Los Angeles, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Boston, US
Locations
South San Francisco, US HQ
Brisbane, US
Employees
Employees
30
Employees
8311% increase
Employees
49
Employees
31738% decrease
Employees
23542% increase
Valuation ($)
Valuation ($)
294.7 k
Valuation ($)
402.7 m
Valuation ($)
173.6 m
Valuation ($)
1.5 b
Valuation ($)
7 b
Twitter followers
Twitter followers
594
Twitter followers
2 k
Twitter followers
226
Twitter followers
3.6 k
Twitter followers
1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
16
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
34.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
19.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
322595
Alexa Website Rank
339305
Alexa Website Rank
313890
Alexa Website Rank
239431
Employee Rating
Employee Rating
3.5
Employee Rating
5
Employee Rating
4.3
Employee Rating
3.8
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
$5.3m (FY, 2015)
Revenue (est.)
$5.6m (FY, 2019)
Revenue (est.)
$600k (FY, 2019)
Revenue (est.)
$428.4m (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$2.1m (FY, 2015)
Cost of goods
N/A
Cost of goods
$912k (FY, 2019)
Cost of goods
$23.9m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
$3.2m (FY, 2015)
Gross profit
N/A
Gross profit
($312k) (FY, 2019)
Gross profit
$404.5m (FY, 2019)
Gross profit
N/A
Net income
Net income
($3.1m) (FY, 2015)
Net income
($44.6m) (FY, 2019)
Net income
($44.7m) (FY, 2019)
Net income
$21.5m (FY, 2019)
Net income
($276.2m) (FY, 2019)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
2 (FY, 2018)
Patents Issued
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
88 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2018)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2018)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2018)
Pre-Clinical Phase Products
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
1 (FY, 2016)
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
3 (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 9m
Total funding raised
$ 153.4m
Total funding raised
$ 609m
Total funding raised
$ 98m
For sources of this data, please see the company profile

View company profiles

Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
317↓ 38% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company